BACKGROUND: The aim of this study was to test the validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, Core Module (QLQ-C30) and Head and Neck Module (QLQ-H&N35) for patients who have undergone surgery due to laryngeal cancer. METHODS: A total of 323 patients from 6 different centers in Germany who had been operated on completed the QLQ-C30 and the QLQ-H&N35 in addition to being surveyed in a personal interview. RESULTS: Multitrait scaling analysis confirmed the proposed scale structure of both questionnaires. Cronbach's alpha of the QLQ-C30 scales ranged from 0.64 (Cognitive Functioning) to 0.94 (Global Health Status); the alpha of the QLQ-H&N35 ranged from 0.55 (Speech) to 0.90 (Sexuality). Known-groups comparisons showed multiple differences in sociodemographic and clinical variables. CONCLUSION: It can be concluded that the QLQ-H&N35, in conjunction with the QLQ-C30, is a reliable instrument that is able to differentiate between diverse groups of patients with laryngeal cancer after surgery. (c) 2008 Wiley Periodicals, Inc. Head Neck, 2009.
BACKGROUND: The aim of this study was to test the validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, Core Module (QLQ-C30) and Head and Neck Module (QLQ-H&N35) for patients who have undergone surgery due to laryngeal cancer. METHODS: A total of 323 patients from 6 different centers in Germany who had been operated on completed the QLQ-C30 and the QLQ-H&N35 in addition to being surveyed in a personal interview. RESULTS: Multitrait scaling analysis confirmed the proposed scale structure of both questionnaires. Cronbach's alpha of the QLQ-C30 scales ranged from 0.64 (Cognitive Functioning) to 0.94 (Global Health Status); the alpha of the QLQ-H&N35 ranged from 0.55 (Speech) to 0.90 (Sexuality). Known-groups comparisons showed multiple differences in sociodemographic and clinical variables. CONCLUSION: It can be concluded that the QLQ-H&N35, in conjunction with the QLQ-C30, is a reliable instrument that is able to differentiate between diverse groups of patients with laryngeal cancer after surgery. (c) 2008 Wiley Periodicals, Inc. Head Neck, 2009.
Authors: S Tribius; M S Meyer; C Pflug; H Hanken; C-J Busch; A Krüll; C Petersen; C Bergelt Journal: Strahlenther Onkol Date: 2018-05-07 Impact factor: 3.621
Authors: F V Dinescu; C Ţiple; Magdalena Chirilă; R Mureşan; T Drugan; M Cosgarea Journal: Eur Arch Otorhinolaryngol Date: 2015-10-28 Impact factor: 2.503
Authors: Veenoo Agarwal; Nadia Corsini; Marion C Eckert; Greg Sharplin; Imogen Ramsey; Kate Gunn; Michael K Fitzgerald; Bogda Koczwara Journal: Support Care Cancer Date: 2021-01-07 Impact factor: 3.603
Authors: A Meyer; A Dietz; D Wollbrück; J Oeken; H Danker; E F Meister; A Sandner; W Völkel; E Brähler; S Singer Journal: HNO Date: 2012-10 Impact factor: 1.284